NCT06489561View on ClinicalTrials.gov

Neural Computations of Goal-directed Decision-making

NAEnrolling by invitationINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

July 1, 2028

Study Completion Date

July 1, 2028

Conditions
Epilepsy Intractable
Interventions
BEHAVIORAL

Cedrus RB-844 response pad; Adtech Behnke-Fried micro-electrodes; Neurolynx electrophysiology system

Devices listed are components of a single intervention that includes: Record patient responses (Cedrus RB-844), record neuronal activity (Neurolynx) from electrodes (Adtech Behnke-Fried)

Trial Locations (1)

90048

Cedars-Sinai Medical Center, Los Angeles

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

collaborator

California Institute of Technology

OTHER

lead

Cedars-Sinai Medical Center

OTHER